ReviewFrontiers in immunology2023

Research progress of biomarkers in the prediction of anti-PD-1/PD-L1 immunotherapeutic efficiency in lung cancer.

Luyao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.